Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.

Ricardo PalaciosElizabeth González PatiñoRoberta de Oliveira PiorelliMonica Tilli Reis Pessoa CondeAna Paula BatistaGang ZengQianqian XinEsper G KallasJorge FloresChristian F OckenhouseChristopher Gast

Published in: Trials (2020)

ClinicalTrials.gov Identifier: NCT0445659 . Registry on 2 July 2020 FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.

Keyphrases

double blind
phase iii
placebo controlled
clinical trial
phase ii
open label
randomized controlled trial
study protocol
coronavirus disease
phase ii study
sars cov